Cell death is a normal feature of animal development. Studies on a number of cell types, such as neurons that die during formation of the animal nervous system and lymphocytes that die during receptor repertoire selection in adults, have shown that cells commonly kill themselves by activating built in suicide mechanisms. Cell deaths that result from engagement of the program result in apoptosis - the ordered dismantling of the cell that results in its silent demise, with packaged cell fragments removed by phagocytic cells. Though apoptosis is often studied within the context of normal development, even in mature animals programmed cell death plays important roles. For example, cell numbers are maintained by a balance between cell proliferation and cell death, with for instance, approximately 1011 neutrophils and 1010 colon epithelial cells turning over per day in humans. Morever, abundant evidence implicates dysregulation of programmed cell death in the pathogenesis of many diseases. Inappropriate increases in apoptotic cell death have been reported in AIDS, neurodegenerative disorders, and ischemic injury; whereas decreases in cell death contribute to cancer, autoimmune diseases, and possibly restenosis. The coordinated cellular demise is mediated by members of a family of cysteine proteases known as caspases whose activation follows characteristic apoptotic stimuli, and whose substrates include most of the proteins where limited cleavage produces the characteristic morphology of apoptosis. Not surprisingly, inhibition of caspases is a strategy adopted by viruses in their attempt to elude the apoptotic response of the cell to the infectious insult, however until now no natural human caspase inhibitors were known. We have recently discovered how members of a human protein family known as IAPs, previously recognized as inhibitors of apoptosis, function. In this grant proposal we present evidence that IAP family proteins are direct inhibitors of selected caspases. We hypothesize that IAPs function as built in regulators of the death pathway through their inhibition of caspases. We plan to test this hypothesis by determining 1) the inhibitory mechanism and specificity, 2) the range of apoptotic stimuli blocked by IAPs and specific mutant constructs, 3) the cellular location and pattern of expression; thereby detailing the functional role of the human IAP family proteins XIAP, cIAP-1, cIAP-2 and NAIP.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG015402-03
Application #
6169128
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Sierra, Felipe
Project Start
1998-06-15
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
3
Fiscal Year
2000
Total Cost
$361,317
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Bratton, Shawn B; Salvesen, Guy S (2010) Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 123:3209-14
Snipas, S J; Drag, M; Stennicke, H R et al. (2008) Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC. Cell Death Differ 15:938-45
Wen, Yunfei; Golubkov, Vladislav S; Strongin, Alex Y et al. (2008) Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 283:2793-803
Santoro, Massimo M; Samuel, Temesgen; Mitchell, Tracy et al. (2007) Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. Nat Genet 39:1397-402
Fujii, Ryoji; Zhu, Changjun; Wen, Yunfei et al. (2006) HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66:9099-107
Eckelman, Brendan P; Salvesen, Guy S; Scott, Fiona L (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7:988-94
Samuel, Temesgen; Welsh, Kate; Lober, Thomas et al. (2006) Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem 281:1080-90
Eckelman, Brendan P; Salvesen, Guy S (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281:3254-60
Samuel, Temesgen; Okada, Kazuya; Hyer, Marc et al. (2005) cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 65:210-8
Berezovskaya, Olga; Schimmer, Aaron D; Glinskii, Anna B et al. (2005) Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 65:2378-86

Showing the most recent 10 out of 39 publications